QQ客服 官方微博 反馈留言

浏览/检索结果: 共15条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2021 作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo 收藏  |  浏览/下载：59/0  |  提交时间：2022/02/14 Epidermal growth factor receptor (EGFR)  uncommon mutation  compound mutation  double uncommon mutation  lung adenocarcinoma (lung AC)   Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 11 作者:  Dong, Ying;  Tang, Bi-xi;  Wang, Qi;  Zhou, Li-wei;  Li, Cong 收藏  |  浏览/下载：73/0  |  提交时间：2022/01/04 idiopathic pulmonary fibrosis  DDRs  kinase inhibitor  indazole derivatives  XBLJ-13  nintedanib  bleomycin-induced pulmonary fibrosismouse model   Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Tao, Zhonghua;  Liu, Jianxia;  Li, Ting;  Xu, Hong;  Chen, Kai 收藏  |  浏览/下载：33/0  |  提交时间：2022/01/10 receptor tyrosine kinase  gene fusion  genomic rearrangments  breast cancer  next-generation sequencing   NGPF2 triggers synaptic scaling up through ALK-LIMK-cofilin-mediated mechanisms 期刊论文 CELL REPORTS, 2021, 卷号: 36, 期号: 7, 页码: 20 作者:  Zhou, Zikai;  He, Guiqin;  Zhang, Xiaoyun;  Lv, Xin;  Zhang, Xiaolin 收藏  |  浏览/下载：65/0  |  提交时间：2021/11/04 Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistance 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 卷号: 202 作者:  Li, Na;  Mao, Weimin;  Gao, Yun;  Wang, Ding;  Song, Zhengbo 收藏  |  浏览/下载：47/0  |  提交时间：2021/08/31 Lung cancer  EGFR-TKI  Resistance  Pleural effusion  Metabolomics  Biomarker   Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 220, 页码: 18 作者:  Xu, Dandan;  Sun, Deqiao;  Wang, Wei;  Peng, Xia;  Zhan, Zhengsheng 收藏  |  浏览/下载：45/0  |  提交时间：2021/08/17 Axl  Cancer  Inhibitor  Pyrrolo[2,3-d]pyrimidine   Transcriptome Regulation by Oncogenic ALK Pathway in Mammalian Cortical Development Revealed by Single-Cell RNA Sequencing 期刊论文 CEREBRAL CORTEX, 2021, 卷号: 31, 期号: 8, 页码: 3911-3924 作者:  Mao, Rui;  Zhang, Xiaoyun;  Kong, Youyong;  Wu, Shanshan;  Huo, Hai-qin 收藏  |  浏览/下载：34/0  |  提交时间：2021/08/17 anaplastic lymphoma kinase  cerebral organoid  neurodevelopment  neural progenitor cell  single-cell RNA sequencing   Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 219, 页码: 12 作者:  Rao, Danni;  Li, Heng;  Ren, Xuelian;  Sun, Yaoliang;  Wen, Cuiyun 收藏  |  浏览/下载：28/0  |  提交时间：2021/08/17 Zeta-chain associated protein kinase 70 kDa (ZAP-70)  Covalent inhibitor  T cell  Autoimmune diseases   The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10 作者:  Pan, Guoqiang;  Chen, Kaiyan;  Yu, Xiaoqing;  Sheng, Jiamin;  Fan, Yun 收藏  |  浏览/下载：38/0  |  提交时间：2021/11/01 Non-small cell lung cancer (NSCLC)  T790M abundance  droplet digital PCR (ddPCR)  next generation sequencing (NGS)  osimertinib   PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy 期刊论文 FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12 作者:  Qi, Si-Min;  Dong, Jinyun;  Xu, Zhi-Yuan;  Cheng, Xiang-Dong;  Zhang, Wei-Dong 收藏  |  浏览/下载：47/0  |  提交时间：2021/06/15 PROTAC  E3 ubiquitin ligase  protein degradation  ubiquitin-proteasome system  cancer therapy